Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omalizumab Before Onset of Exacerbations

NCT05332067 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.

NCT NCT05332067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05332067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omalizumab Before Onset of Exacerbations
Lead sponsor
Children's National Research Institute
Phase
Phase 2
Overall status
Recruiting
Start date
May 1, 2022
Completion date
March 1, 2028
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma in children, atopy, viral upper respiratory infection